tiprankstipranks
OpGen Inc (OPGN)
NASDAQ:OPGN

OpGen (OPGN) Stock Price & Analysis

572 Followers

OPGN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.17 - $9.08
Previous Close$0.43
Volume84.73K
Average Volume (3M)4.54M
Market Cap
$4.38M
Enterprise Value$13.85M
Total Cash (Recent Filing)$3.24M
Total Debt (Recent Filing)$12.70M
Price to Earnings (P/E)>-0.1
Beta1.43
Mar 26, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.52
Shares Outstanding10,013,524
10 Day Avg. Volume193,031
30 Day Avg. Volume4,538,906
Standard Deviation0.33
R-Squared0.02
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)-11.56
Price to Sales (P/S)6.08
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.80
Enterprise Value/Gross Profit-19.44
Enterprise Value/Ebitda-0.43
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0


Financials

Annual

Ownership Overview

52.45% Insiders
0.96% Mutual Funds
2.39% Other Institutional Investors
44.20% Public Companies and
Individual Investors

OPGN FAQ

What was OpGen Inc’s price range in the past 12 months?
OpGen Inc lowest stock price was $0.17 and its highest was $9.08 in the past 12 months.
    What is OpGen Inc’s market cap?
    Currently, no data Available
    When is OpGen Inc’s upcoming earnings report date?
    OpGen Inc’s upcoming earnings report date is Mar 26, 2024 which is in 110 days.
      How were OpGen Inc’s earnings last quarter?
      OpGen Inc released its earnings results on Nov 14, 2023. The company reported -$0.46 earnings per share for the quarter, missing the consensus estimate of -$0.43 by -$0.03.
        Is OpGen Inc overvalued?
        According to Wall Street analysts OpGen Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does OpGen Inc pay dividends?
          OpGen Inc does not currently pay dividends.
          What is OpGen Inc’s EPS estimate?
          OpGen Inc’s EPS estimate is -$0.25.
            How many shares outstanding does OpGen Inc have?
            OpGen Inc has 10,013,524 shares outstanding.
              What happened to OpGen Inc’s price movement after its last earnings report?
              OpGen Inc reported an EPS of -$0.46 in its last earnings report, missing expectations of -$0.43. Following the earnings report the stock price went down -2.041%.
                Which hedge fund is a major shareholder of OpGen Inc?
                Currently, no hedge funds are holding shares in OPGN

                ---

                Company Description

                OpGen Inc

                OpGen, Inc. engages in the development of molecular information products and services for global healthcare settings. It helps to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.

                ---

                Top 5 ETFs holding OPGN

                Currently, no data available
                Please return soon. This page is being updated.
                Up to five ETFs with an Outperform Smart Score that hold OPGN. The ETFs are listed according to market value of OPGN within the ETF

                Forecast EPS vs Actual EPS


                Similar Stocks
                Company
                Price & Change
                Follow
                Arbutus Biopharma
                vTv Therapeutics
                Novavax

                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis